Polyp Biopsy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Polyp Biopsy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
According to Renub Research analysis China Biopsy Market will be USD 8.1 Billion by 2026. Forecast by Cancer Segment, Volume of Biopsy and Patient Diagnosed Numbers, Company Analysis. Follow the Link for More Information: https://www.renub.com/china-biopsy-market-p.php
iGATE Research has released a report on "Global - Biopsy Device Market (By Country Wise and Product Segment) and Biopsy Procedure Volume Analysis To 2020" Click here to view the complete report: http://www.igateresearch.com/ProductDetail.php?pd_name=Global%20Biopsy%20Device%20Market%20and%20Forecast%20To%202020 Contact US iGATE Research PVT LTD Ravi Sinha Sales Manager Marketing and Sales Divison Email: ravi.sinha@igateresearch.com Contact: +91-858-684-0791, +91-706-527-9335 (INDIA) Web: www.igateresearch.com
New report, "China Biopsy Procedures Outlook to 2023", provides key procedures data on the China Biopsy Procedures. The report provides procedure volumes within market segments - Breast Biopsy Procedures, Colorectal Biopsy Procedures, Leukemia Biopsy Procedures, Liver Biopsy Procedures, Lung Biopsy Procedures, Other Indications Biopsy Procedures, Prostate Biopsy Procedures and Thyroid Biopsy Procedures.
Liquid Biopsy Market Forecast to 2027 – COVID-19 Impact and Global Analysis – by Product & Services (Equipment, Reagents & Kits, and Services), Sample (Blood Based, Urine Based, and Other Samples), Circulating Biomarker [Circulating Tumor Cells (CTC), Exosomes, and Free Nucleic Acid], Application [Noninvasive Prenatal Testing (NIPT), Oncology, Transplant Diagnostics, and Other Applications], and End User (Academic & Research Institutes, Hospitals, Reference Laboratories, and Other End Users)
According to the latest research report by IMARC Group, The global liquid biopsy market size reached US$ 1.8 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 4.3 Billion by 2028, exhibiting a growth rate (CAGR) of 15.3% during 2023-2028. More Info:- https://www.imarcgroup.com/liquid-biopsy-market
Liquid biopsy reduces the apprehension of patients regarding pain and provides a safe and effective method of diagnosis. As a result, there has been increasing demand for a non-invasive alternative, such as liquid biopsy, over tissue biopsy that involves the painful extraction of diseased tissue, which is fueling the market growth. Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: Visit the following link: https://www.imarcgroup.com/liquid-biopsy-market E-mail: sales@imarcgroup.com Contact: +91-120-415-5099
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027.
The needle biopsy market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with a CAGR of 4.2% in the forecast period of 2021 to 2028 and is expected to reach USD 154.18 million by 2028.
The biopsy devices market is anticipated to reach US$ 3,584.20 million by 2027 from US$ 2,230.86 million in 2019. The market is projected to grow at a CAGR of 6.2% from 2020 to 2027.
The liquid biopsy market size is projected to reach US$ 8,123.85 million by 2027 from US$ 3,861.49 million in 2019. The liquid biopsy market CAGR is estimated to grow at 9.9% from 2020 to 2027.
The needle biopsy market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with a CAGR of 4.2% in the forecast period of 2021 to 2028 and is expected to reach USD 154.18 million by 2028.
iGATE Research has released a research report on “Liquid Biopsy Market (by Circulating Biomarker, Product, Application, End User, Clinical Application, Cancer Types, Sample Type, Regional & Country Wise Analysis), Initiatives, Funding and 20 Company Profile - Global Forecast to 2026” Click here to view the complete report: http://igateresearch.com/FullReportDetail.php?p=144 Contact US iGATE Research PVT LTD Ravi Sinha Sales Manager Marketing and Sales Divison Email: ravi.sinha@igateresearch.com Contact: +91-858-684-0791, +91-821-092-7469 (INDIA) Web: www.igateresearch.com
Surge in number of cancer patients and rise in preference for minimally invasive procedures are some key factors driving liquid biopsy market revenue growth
The liquid biopsy market size is projected to reach US$ 8,123.85 million by 2027 from US$ 3,861.49 million in 2019. The liquid biopsy market CAGR is estimated to grow at 9.9% from 2020 to 2027.
iGATE Research has released a research report on “Biopsy Devices Market (By Product Segment, Application, End Users, and Country) and Biopsy Procedure Volume Analysis, Mergers and Acquisitions, Recent Developments, Trends, 15 Company Profiles & Biopsy Product Analysis – Global Forecast to 2025” Click here to view the complete report: https://www.igateresearch.com/biopsy-devices-market-by-product-segment-application-end-users-and-country-and-biopsy-procedure-volume-analysis-mergers-and-acquisitions-recent-developments-trends-15-company-profiles-biopsy-product-analysis-global-forecast-to-2025.html Contact US iGATE Research PVT LTD Ravi Sinha Sales Manager Marketing and Sales Divison Email: ravi.sinha@igateresearch.com Contact: +91-858-684-0791, +91-821-092-7469 (INDIA) Web: www.igateresearch.com
This report studies Prostate Biopsy Needle in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.
The Prostate Cancer Diagnostics Market size will be XX million (USD) in 2022 in China, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022.
The global aspiration & biopsy needles market size was USD 875.3 Million in 2021 and is expected to register a revenue CAGR of 6.8% during the forecast period, according to latest analysis by Emergen Research. Rising prevalence of cancer cases owing to various lifestyle changes, rapid urbanization and rising pollution levels, and changing consumption habits and increasing cancer awareness programs and screening and tests by governments and various global health organizations are some of the key factors driving global aspiration and biopsy needles market revenue growth. According to World Cancer Research Fund International, around 18,094,716 million cases of cancer were diagnosed in 2020.
This report studies Stereotacticguided Biopsy Instrument in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering C. R. Bard, Inc. U.S. Becton, Dickinson and Company U.S.
The market for biopsy guidance systems held the largest share in 2015 and is expected to continue to lead the market throughout the forecasting period. The biopsy guidance systems is followed by the needle based biopsy guns segment. Vacuum-assisted biopsy devices represent the fastest growing segment, and increased Medicare reimbursement given for such procedures is expected to help fuel demand. The market for biopsy needles is expected to remain relatively constant throughout the forecasting period. Forceps and Other devices are expected to account for lesser shares as compared to the other segments, due to their specific applications and also risks associated with their use. Complete report available at: http://www.marketreportsonline.com/563956.html.
Get a Sample Brochure @ https://tinyurl.com/y939vl8m Fibereoptic Bronchoscopy Report by Material, Application, and Geography – Global Forecast to 2021 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, united Kingdom, Japan, South Korea and China).
The increasing prevalence of the disease represents one of the significant factors strengthening the biopsy devices market growth. Apart from this, the increasing awareness among individuals about the availability of diagnostic and screening procedures for chronic diseases is positively influencing the demand for integrated technologies, such as stereotactic-guided biopsies. For more information, request for a free sample report here: https://www.imarcgroup.com/biopsy-devices-market/requestsample
Giant cell arteritis is a rare disease of inflammation of blood vessels thereby restricting the flow of blood and damaging vital organs. Giant cell arteritis is the inflammation of blood vessels, veins and arteries in the head, neck and arms.
This report studies the Prostate Biopsy Devices market status and outlook of global and major regions, from angles of players, regions, product types and end industries. Avail Sample Brochure of report http://bit.ly/2oTngVO Read analysis @ http://bit.ly/2pDZgVE
Looking forward, the biopsy devices market value is projected to reach a strong growth during the forecast period (2021-2026). More info:- https://www.imarcgroup.com/biopsy-devices-market
A new study on the global Liquid Biopsy market has been published by AllTheResearch (ATR). It offers detailed information on key market dynamics, including drivers, trends, and challenges for the global Liquid Biopsy market as well as its structure. The study offers valuable information on the global Liquid Biopsy market to illustrate how the market is expected to expand during the forecast period i.e. 2020–2023.
Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Vacuum-assisted Biopsy Devices in these regions, from 2012 to 2023 (forecast), covering North America (United States, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) Asia-Pacific (China, Japan, Korea, India and Southeast Asia) South America (Brazil, Argentina, Columbia) Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
"United States General Surgery Market Outlook to 2020", provides key market data on the United States General Surgery devices market. The report provides value, in millions of US dollars, and volume (in units) within market categories - Bronchoscopes, Laryngoscopes, Ureteroscopes, Cystoscopes, Colonoscopes, Sigmoidoscopes, Esophagoscopes & Gastroscopes, Duodenoscopes, Laparoscopes, Hysteroscopes, Sinuscopes, Resectoscopes, Endoscopy Visualization Systems, Endoscopy Visualization System Components, Endoscopic Reprocessors, Endoscopy Fluid Management Systems, Capsule Endoscopy Systems, Surgical Generators, Bariatric Surgery Devices, Aesthetic Lasers and Energy Devices, Biopsy Devices, Hernia Repair, Non-Vascular Stents and Gynecological Devices. See Full Report @ bit.ly/1wL9VIN
“Brazil General Surgery Market Outlook to 2020", provides key market data on the Brazil General Surgery devices market. The report provides value, in millions of US dollars, and volume (in units) within market categories - Bronchoscopes, Laryngoscopes, Ureteroscopes, Cystoscopes, Colonoscopes, Sigmoidoscopes, Esophagoscopes & Gastroscopes, Duodenoscopes, Laparoscopes, Hysteroscopes, Sinuscopes, Resectoscopes, Endoscopy Visualization Systems, Endoscopy Visualization System Components, Endoscopic Reprocessors, Endoscopy Fluid Management Systems, Capsule Endoscopy Systems, Surgical Generators, Bariatric Surgery Devices, Aesthetic Lasers and Energy Devices, Biopsy Devices, Hernia Repair, Non-Vascular Stents and Gynecological Devices. See Full Report : http://bit.ly/1D9eKix
The growth is mainly led by product and technological innovations, increasing incidence of breast cancer cases, rising propensity for minimally invasive surgeries, and mounting number of breast cancer screening programs.
Increasing cancer prevalence, preference for non-invasive diagnostics techniques and shift towards personalized medicines are the key factors driving the global liquid biopsy market.
First China, the country where the virus originated, and then other countries incrementally saw R&D investment into Coronavirus diagnostics and treatment overtake R&D investment into cancer. Going by this bare fact, it would appear that the demand for liquid biopsy technology would drop. However, this was not the case and sales of liquid biopsy products actually grew faster in 2020 than nearly all earlier estimates.
The global cancer diagnostics market refers to the market for products and services used to diagnose various types of cancer. The market includes diagnostic devices, such as imaging equipment and biopsy devices, as well as diagnostic tests and services.
Thyroids are situated in the lower front of the neck. The structure of the thyroid is like a butterfly. Thyroids work as a control metabolism that releases hormones all over the body. These hormones play a very important role in the functioning of the body. Thyroid cancer evolves when the cells go through mutation. When the abnormal cells increase in the thyroid, it can lead to a tumor in the thyroid. The treatment of thyroid cancer is possible if it is diagnosed at an early stage.
The blood cancer detection market is expected to continue to grow in the coming years, driven by the factors mentioned above. The development of new and improved diagnostic technologies, such as liquid biopsy, is expected to further drive the growth of the market. Liquid biopsy is a minimally invasive technique that can be used to detect blood cancer by analyzing cell-free DNA circulating in the blood.
Global Cancer Diagnostics Market is forecasted to grow at a CAGR of 8.8% during 2016 – 2021F, on account of rising incidences of cancer globally, along with the increasing technological advancement driven by focus on cancer research.
The growth of the studied market is driven due to the rising incidence of oncology diseases, the need for efficient prognosis and early diagnosis of various forms of cancer, and rising initiatives by key players in the development of innovative solutions to meet the increasing demand for efficient diagnostics. Several tests, including physical examination, laboratory tests, imaging tests, and biopsies have traditionally been performed in cancer diagnosis. Each step of the usual diagnostic procedure with the prognosis and therapeutic decision made by oncologists comes with a well-defined diagnosis to avoid potential complications. This highlights the crucial importance of diagnosis throughout the entire oncology lifecycle, surpassing the therapeutic regime's significance.
The Global Special Purpose Needles Market was valued at US$ 10.44 billion in 2021 and is predictable to reach US$ 22.01 billion by 2030 which is projected to attain a CAGR of 8.6 % during the forecast period from 2021- 2030. Needles are referred as a device made up of metal, glass, or rubber tubes used for delivering drugs and collecting fluids from the body.
Electron microscope is an electronic device that is used to observe tiny organisms or particles which are difficult to see with naked eyes. The electron microscope is used in various end user industries for its applications. The Electron Microscopy Market deals with the demand and supply, production and scope of innovation in electron microscopy technology during 2015-2020.
Colposcope is a medical diagnostic procedure to examine an illuminated, magnified view of the cervix and the tissues of the vagina and vulva. Many premalignant lesions and malignant lesions in these areas have discernible characteristics which can be detected through the examination. It is done using a Colposcope, which provides an enlarged view of the areas, allowing the colposcopies to visually distinguish normal from abnormal appearing tissue and take directed biopsies for further pathological examination. The main goal of Colposcope is to prevent cervical cancer by detecting precancerous lesions early and treating them.
Anatomic Pathology Market, Size, Share, Market Intelligence, Company Profiles, Market Trends, Strategy, Analysis, Forecast 2015-2022 The Global anatomic pathology market is expected to grow at a CAGR of 6.8 % during 2017-2022. The branch of medicine that studies the effect of disease on the structure of body organs, both as a whole (grossly) and microscopically is known as Anatomic (or anatomical) pathology.
According to our latest study on "Circulating Tumor Cell (CTC) Diagnostics Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Technology (CTC Detection and Enrichment Method, CTC Direct Detection Method, and CTC Analysis), Application (Clinical/Liquid Biopsy and Research), and End User (Hospitals and Clinics, Research and Academic Institutes, and Diagnostic Centers)," the market is expected to grow from US$ 1,909.41 million in 2021 to US$ 3,656.38 million by 2028; it is estimated to grow at a CAGR of 9.7% from 2021 to 2028.
In IVD market oncology is one of the most sought-after segments by the manufacturers. Non-invasive cancer testing is expected to be a hot market in 2019. Qiagen, one of the global MNC, has been pioneering the use of liquid biopsy-based companion diagnostics as a less-invasive option to complement surgical biopsies for genomic profiling of cancers.
The Asian orthobiologics market is segmented and forecasted based on products and end users. Based on geography, the market has been segmented into Japan, China, India, Republic of Korea, and the Rest of Asia. This report also includes the market share, value chain analyses, and market metrics such as drivers, restraints, and upcoming opportunities.
MarkNtel Advisors, in its latest report, forecasts a Compound Annual Growth Rate (CAGR) of approximately 8.6% for the Global Breast Cancer Treatment Market throughout the forecast period (2022-27).